Zivo Total Operating Expenses from 2010 to 2026
| ZIVOW Stock | USD 0.05 0.00 0.00% |
Total Operating Expenses | First Reported 1999-09-30 | Previous Quarter 1.7 M | Current Value 1 M | Quarterly Volatility 1.1 M |
Check Zivo Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zivo Bioscience's main balance sheet or income statement drivers, such as Interest Expense of 25.1 K, Other Operating Expenses of 16.3 M or Total Operating Expenses of 16.2 M, as well as many indicators such as Price To Sales Ratio of 563, Dividend Yield of 0.0 or Days Sales Outstanding of 5.61. Zivo financial statements analysis is a perfect complement when working with Zivo Bioscience Valuation or Volatility modules.
Zivo | Total Operating Expenses | Build AI portfolio with Zivo Stock |
The evolution of Total Operating Expenses for Zivo Bioscience Warrants provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Zivo Bioscience compares to historical norms and industry peers.
Latest Zivo Bioscience's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Zivo Bioscience Warrants over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Zivo Bioscience's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zivo Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Zivo Total Operating Expenses Regression Statistics
| Arithmetic Mean | 6,875,406 | |
| Geometric Mean | 3,864,394 | |
| Coefficient Of Variation | 69.15 | |
| Mean Deviation | 3,765,988 | |
| Median | 6,330,186 | |
| Standard Deviation | 4,754,640 | |
| Sample Variance | 22.6T | |
| Range | 16.2M | |
| R-Value | 0.94 | |
| Mean Square Error | 2.6T | |
| R-Squared | 0.89 | |
| Slope | 889,744 | |
| Total Sum of Squares | 361.7T |
Zivo Total Operating Expenses History
About Zivo Bioscience Financial Statements
Zivo Bioscience investors use historical fundamental indicators, such as Zivo Bioscience's Total Operating Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Zivo Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 15.4 M | 16.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Zivo Stock Analysis
When running Zivo Bioscience's price analysis, check to measure Zivo Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zivo Bioscience is operating at the current time. Most of Zivo Bioscience's value examination focuses on studying past and present price action to predict the probability of Zivo Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zivo Bioscience's price. Additionally, you may evaluate how the addition of Zivo Bioscience to your portfolios can decrease your overall portfolio volatility.